1832 Asset Management’s Insmed INSM Stock Holding History

1832 Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,900	Closed	-$4.73M	–	667
2026 Q1	$4.73M	Buy	+28,900	New	+$4.44M	﹤0.01%	431
2025 Q4	–	Sell	-584,800	Closed	-$84.2M	–	732
2025 Q3	$84.2M	Buy	+584,800	New	+$71.6M	0.07%	147
2025 Q2	–	Sell	-487,800	Closed	-$37.2M	–	713
2025 Q1	$37.2M	Buy	+487,800	New	+$37.3M	0.03%	230

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

1832 Asset Management's INSM Position: Q2 2026 in Review

1832 Asset Management sold out of Insmed (INSM) in Q2 2026, closing a stake of 28,900 shares — an estimated $4.73M sold.

1832 Asset Management first reported a position in INSM in Q1 2025 and held it in 3 quarters. The position peaked at $84.2M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

1832 Asset Management reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
1832 Asset Management sold 28,900 Insmed shares in Q2 2026, an estimated $4.73M.
1832 Asset Management first reported a position in Insmed in Q1 2025 and held it in 3 quarters.
1832 Asset Management's Insmed position peaked at $84.2M in Q3 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.